USPTO serial 79077372
MACROFINDER
Reviewed by CopyMark Law Group
Reg. 3950034Status 709
- Filing date
- Status date
- Registration date
- Apr 26, 2011
- Examiner
- KING, LINDA M
- Law office
- GENERIC WEB UPDATE
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MACROFINDER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Allschwil, CH
Allschwil, CH
Allschwil, CH
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Scott D. Woldow
Scott D. Woldow Smith, Gambrell, Russell, LLP1055 Thomas Jefferson St. NW, Suite 400Washington, DC 20007UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry and science | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical anti-allergic preparations and substances, Pharmaceutical for the treatment of erectile dysfunction, Pharmaceutical preparations, namely, anticoagulants, Pharmaceutical preparations, namely, antidepressants, Pharmaceutical preparations, namely, appetite suppressants, Pharmaceutical preparations for use in chemotherapy, Pharmaceutical preparation for the treatment of gout, Pharmaceutical preparations for the treatment of heart rhythm disorders, Pharmaceutical preparations for the treatment of stem cell mobilization, Pharmaceutical preparations for the treatment of infectious diseases, Pharmaceutical preparations acting on the central nervous system, Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases, Pharmaceutical preparations for animal skincare, Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension, Pharmaceutical preparations for ocular or intraocular surgery, Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis, Pharmaceutical preparations for treating allergic rhinitis and asthma, Pharmaceutical preparations for treating diabetes, Pharmaceutical preparations for treating skin disorders, Pharmaceutical preparations for use in dermatology, Pharmaceutical preparations for wounds, Pharmaceutical preparations for use in urology, Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in humans, Pharmaceutical products and preparations against dry skin caused by pregnancy, Pharmaceutical products and preparations for chloasma, Pharmaceutical products and preparations for hydrating the skin during pregnancy, Pharmaceutical products and preparations for pregnancy blemishes, Pharmaceutical products and preparations for preventing skin blemishes during pregnancy, Pharmaceutical products and preparations to prevent stretch marks, Pharmaceutical products and preparations to prevent swelling in the legs, Pharmaceutical products for ophthalmological use, Pharmaceutical products for the treatment of bone diseases, Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer, Pharmaceutical products for treating respiratory diseases and asthma, Pharmaceutical skin lotions, Pharmaceutical solutions used in dialysis, Pharmaceuticals for the treatment of erectile dysfunction, Pharmaceuticals, namely, antihelmintics, Pharmaceuticals, namely, inducers of erections, Pharmaceuticals, namely, lipid lowering agents, Pharmaceuticals, namely, psychotropics, Pharmaceuticals, namely, anti-infectives; and sanitary preparations for medical purposes; dietetic foods adapted for medical use, medical plasters, dressings for wounds, burns, surgery; dental impression materials; disinfectants for hygienic purposes | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services in the nature of scientific research in the fields of pharmaceuticals and bio-chemistry [; design for others in the fields of pharmaceuticals and bio-chemistry; industrial analysis and research services in the fields of pharmaceuticals and bio-chemistry] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Polyphor AG
- Other trademarks owned by Polyphor AG
- Other trademarks owned by Polyphor AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named MACROFINDER
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 29, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 19, 2022 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Aug 29, 2022 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Aug 29, 2022 | INPC | INVALIDATION PROCESSED | — |
| Jul 26, 2022 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 7, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 26, 2021 | C71T | CANCELLED SECTION 71 | — |
| Apr 26, 2020 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Dec 5, 2019 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Jul 19, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 6, 2018 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Feb 22, 2018 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Feb 22, 2018 | INPC | INVALIDATION PROCESSED | — |
| Feb 21, 2018 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jun 21, 2017 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Jun 21, 2017 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Jun 20, 2017 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 19, 2017 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 18, 2017 | ES71 | TEAS SECTION 71 RECEIVED | — |
| May 14, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 21, 2011 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 21, 2011 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 26, 2011 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 26, 2011 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 19, 2011 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Feb 8, 2011 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 8, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 3, 2011 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 3, 2011 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 4, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 4, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 30, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 30, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 22, 2010 | ALIE | ASSIGNED TO LIE | — |
| Nov 19, 2010 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 30, 2010 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 30, 2010 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 30, 2010 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 15, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 15, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 15, 2010 | ALIE | ASSIGNED TO LIE | — |
| Jun 29, 2010 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 29, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 5, 2010 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 8, 2010 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 8, 2010 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 5, 2010 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 4, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 3, 2010 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 26, 2010 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 22, 2010 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 21, 2010 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |